Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabotyping of Overweight and Obese Children Towards Early Detection of Insulin Resistance and Low-grade Inflammation by Means of a Rectal Sampler

NCT04632511 is registered in ClinicalTrials.gov with University Ghent as lead sponsor.

NCT NCT04632511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04632511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabotyping of Overweight and Obese Children Towards Early Detection of Insulin Resistance and Low-grade Inflammation by Means of a Rectal Sampler
Lead sponsor
University Ghent
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 15, 2021
Completion date
December 31, 2026
Enrollment
232 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disease, obesity, infant